Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
Abstract Schizophrenia (SCZ) is a psychiatric disorder characterized by a wide range of positive, negative and cognitive symptoms, along with an increased risk of metabolic syndrome and cardiovascular disease that contribute to a 15–20-year reduced life expectancy. Autonomic dysfunction, in the form...
Guardado en:
Autores principales: | Nicolette Stogios, Alexander Gdanski, Philip Gerretsen, Araba F. Chintoh, Ariel Graff-Guerrero, Tarek K. Rajji, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97938c5b0ea542a3a8d6bd15b45983a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia
por: Kenya A. Costa-Dookhan, et al.
Publicado: (2021) -
Predictors and diagnosis of cardiac autonomic nervous dysfunction in patients with type 1 and type 2 diabetes mellitus
por: Kirill A. Popov, et al.
Publicado: (2017) -
Discrete and effortful imagined movements do not specifically activate the autonomic nervous system.
por: Laurent Demougeot, et al.
Publicado: (2009) -
Investigating the autonomic nervous system response to anxiety in children with autism spectrum disorders.
por: Azadeh Kushki, et al.
Publicado: (2013) -
Device for Controlling Stimulus Self-Application During Autonomic Nervous System Tests
por: Żyliński M, et al.
Publicado: (2021)